Seres Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FLAGSHIP PIONEERING INC. | 11/14/2024 | 23.12 M | $21.87 M | 0.00% | 15.14% |
FMR LLC | 11/13/2024 | 22.86 M | $21.63 M | 0.62% | 14.97% |
VANGUARD GROUP INC | 11/13/2024 | 6.06 M | $5.73 M | -3.58% | 3.97% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.76 M | $1.67 M | 100.00% | 1.15% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.39 M | $1.31 M | 22.50% | 0.91% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 1.19 M | $1.13 M | -16.46% | 0.78% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 1.02 M | $966,874 | -42.51% | 0.67% |
MORGAN STANLEY | 11/14/2024 | 802,325 | $759,080 | 368.96% | 0.53% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 748,718 | $708,362 | 42.36% | 0.49% |
SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 433,900 | $410,511 | 621.96% | 0.28% |
VONTOBEL HOLDING LTD. | 10/16/2024 | 394,826 | $373,545 | 100.00% | 0.26% |
STATE STREET CORP | 11/14/2024 | 383,248 | $362,591 | 12.87% | 0.25% |
LION POINT CAPITAL, LP | 11/14/2024 | 340,761 | $322,394 | 0.00% | 0.22% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 312,500 | $296,875 | -6.66% | 0.20% |
CANTOR FITZGERALD, L. P. | 11/14/2024 | 280,565 | $265,443 | 100.00% | 0.18% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 250,000 | $236,525 | 100.00% | 0.16% |
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 200,000 | $189,220 | -91.69% | 0.13% |
GROUP ONE TRADING, L.P. | 11/14/2024 | 193,518 | $183,087 | 73.95% | 0.13% |
CITADEL ADVISORS LLC | 11/14/2024 | 190,300 | $180,043 | 92.81% | 0.12% |
CITADEL ADVISORS LLC | 11/14/2024 | 126,300 | $119,492 | -3.51% | 0.08% |
LPL FINANCIAL LLC | 11/08/2024 | 122,225 | $115,637 | -13.08% | 0.08% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 122,133 | $115,538 | 16.27% | 0.08% |
ENGINEERS GATE MANAGER LP | 11/14/2024 | 103,974 | $98,370 | 15.58% | 0.07% |
PROVIDENCE WEALTH ADVISORS, LLC | 11/14/2024 | 98,500 | $76,850 | 29.18% | 0.06% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 77,200 | $73,340 | 100.00% | 0.05% |
HIGHTOWER ADVISORS, LLC | 11/14/2024 | 70,000 | $66,000 | 27.27% | 0.05% |
JANNEY MONTGOMERY SCOTT LLC | 10/29/2024 | 69,098 | $65,000 | -7.99% | 0.05% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 67,392 | $64,000 | -74.80% | 0.04% |
TUDOR INVESTMENT CORP ET AL | 11/14/2024 | 61,977 | $58,636 | 0.00% | 0.04% |
VIRTU FINANCIAL LLC | 11/20/2024 | 58,791 | $56,000 | 44.81% | 0.04% |
INVESCO LTD. | 11/12/2024 | 55,218 | $52,242 | 40.65% | 0.04% |
HARBOURVEST PARTNERS LLC | 11/14/2024 | 49,363 | $46,702 | 0.00% | 0.03% |
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 11/12/2024 | 48,344 | $45,738 | 82.28% | 0.03% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 11/14/2024 | 45,617 | $43,158 | 5.36% | 0.03% |
POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 44,972 | $42,548 | -64.76% | 0.03% |
SQUAREPOINT OPS LLC | 11/14/2024 | 44,747 | $42,335 | 100.00% | 0.03% |
KESTRA ADVISORY SERVICES, LLC | 11/13/2024 | 39,971 | $37,817 | -22.42% | 0.03% |
WOLVERINE TRADING, LLC | 11/14/2024 | 36,500 | $33,540 | 80.69% | 0.02% |
UBS GROUP AG | 11/14/2024 | 34,395 | $32,538 | -82.86% | 0.02% |
WOLVERINE TRADING, LLC | 11/14/2024 | 32,000 | $29,405 | 100.00% | 0.02% |
BAYESIAN CAPITAL MANAGEMENT, LP | 11/14/2024 | 31,000 | $29,329 | 100.00% | 0.02% |
11/14/2024 | 24,900 | $23,558 | 0.00% | 0.02% | |
WOLVERINE TRADING, LLC | 11/14/2024 | 22,140 | $20,344 | -11.79% | 0.01% |
ARETE WEALTH ADVISORS, LLC | 11/18/2024 | 21,000 | $20,000 | -5.19% | 0.01% |
JANE STREET GROUP, LLC | 11/15/2024 | 20,870 | $19,744 | -97.05% | 0.01% |
STIFEL FINANCIAL CORP | 11/14/2024 | 20,000 | $18,922 | 0.00% | 0.01% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 18,300 | $17,313 | -16.81% | 0.01% |
CLEAR CREEK FINANCIAL MANAGEMENT, LLC | 10/29/2024 | 18,200 | $17,219 | -5.21% | 0.01% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 17,490 | $16,547 | 100.00% | 0.01% |
AUOUR INVESTMENTS LLC | 10/30/2024 | 17,000 | $13,109 | 0.00% | 0.01% |
Seres Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 126 institutional investors and hedge funds held shares of Seres Therapeutics, Inc.. The most heavily invested institutionals were:
Flagship Pioneering Inc.: 23.12 M
FMR LLC: 22.86 M
VANGUARD GROUP INC: 6.06 M
BlackRock Funding, Inc. /DE: 1.76 M
GEODE CAPITAL MANAGEMENT, LLC: 1.39 M
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 1.19 M
41.53% of Seres Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 94.17 M shares in the last 24 months. This purchase volume represents approximately $86.64 M in transactions.